EDITORIAL article
Front. Hum. Neurosci.
Sec. Brain Imaging and Stimulation
Volume 19 - 2025 | doi: 10.3389/fnhum.2025.1640565
This article is part of the Research TopicTranscranial Electrical Stimulation (tACS, tDCS, tRNS) in Basic and Clinical Neuroscience: Current Progress and Future DirectionsView all 8 articles
Editorial: Transcranial Electrical Stimulation (tACS, tDCS, tRNS) in Basic and Clinical Neuroscience: Current Progress and Future Directions
Provisionally accepted- 1Universität der Bundeswehr München, Neubiberg, Germany
- 2Universita degli Studi di Messina, Messina, Italy
- 3Rijksuniversiteit Groningen, Groningen, Netherlands
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Transcranial Electrical Stimulation (tACS, tDCS, tRNS) in Basic and Clinical Neuroscience: Current Progress and Future Directions Transcranial electrical stimulation (tES) as a non-invasive brain stimulation technique has been used to study brain physiology for many years now (Nitsche and Paulus 2000;Antal et al. 2017). Within this period, rapid advancement in understanding its mechanisms of action (Liu et al. 2018;Jackson et al. 2016;Yavari et al. 2018), and optimization of neuromodulatory effects have taken place (Agboada et al. 2019;2020;Mosayebi Samani et al. 2019a;2019b;Wischnewski et al. 2019), with evidence from healthy and clinical populations (Alizadehgoradel et al. 2024;Ney et al. 2021;Vicario and Nitsche 2013). TES methods, including transcranial direct current, alternating current, and random noise stimulation (tDCS, tACS, tRNS) operate via the application of weak currents through electrodes on the scalp with the aim of influencing brain physiology (Antal et al. 2017). So far, tDCS and tACS have been employed to enhance performance in cognitive and behavioural tasks (Fröhlich et al. 2015;Reinhart et al. 2017), as well as treat neuropsychiatric disorders such as depression, Alzheimer's, Parkinson's, stroke, schizophrenia and many more in clinical trials (Lefaucheur et al. 2017;Elyamany et al. 2021). While progress has been significant, challenges remain, including inter-subject variability, sub-optimal stimulation parameters, and lack of long-term effects (Bland and Sale 2019;Ammann et al. 2017;Strube et al. 2016;Wiethoff et al. 2014). This research topic focused on tES progress, and how it may shape future behavioural and cognitive applications, as well as therapeutic use.Basic physiological mechanisms of tES have been established in animal (Ranieri et al. 2012;Rahman et al. 2013;Krause et al. 2019;Wischnewski et al. 2024), human (Nitsche et al. 2005;Mosayebi-Samani et al. 2023;Woods et al. 2016), and computational models (Bikson et al. 2015;Bonaiuto and Bestmann 2015). However, the exact mechanisms by which these effects lead to behavioural modulation is still lacking. In this research topic, four potential mechanisms of tACS-induced after-effects were discussed by Agboada et At the centre of future tES studies is the continuous investigation of mechanistic processes underlying observed after-effects. When optimizing tES at the individual and group levels, domain-specific aims must inform safety and tolerability considerations.In this research topic, Chen et al. explored the rehabilitative effects of tDCS and exergames on smartphone addiction, combined with electroencephalography. TDCS improved executive control and decision-making abilities, and increased P300 amplitudes in frontal, central and parietal cortical regions. These changes were stable over a 4-week follow-up. Similarly, using functional neuroimaging to test the simultaneous and cumulative effects of tDCS in multiple sclerosis patients, Muccio et al. found that tDCS acutely enhanced metabolic activity which persisted post-stimulation. At follow-up after 20 sessions of home-based tDCS with an adaptive cognitive task, the authors reported sustained after-effects of the stimulation. These studies emphasize the importance of neurophysiological evidence of tES effects, which offers mechanistic details about the stimulation efficacy. Currently, only a handful of clinical trials measured neurophysiological and clinical measurement outcomes. Clinical studies with tES should therefore utilize a multi-modal paradigm to correlate brain and behavioural/clinical changes. Furthermore, in a pre-registered clinical trial, Xue et al. presented a protocol for assessing the effects of tDCS in patients with post-operative delirium after elective hip fracture surgery. They plan to recruit 160 patients over the age of 65 years. Using functional near infrared spectroscopy for evaluating brain metabolic changes before and after tDCS, the authors will ascertain the efficacy of the stimulation in lowering post-operative delirium.The future of tES lies in the optimization of stimulation parameters at the individual and group levels through different experimental and computational approaches (Zrenner and Ziemann 2024). One potential individualized approach to modulate alpha oscillations applied by Carrasco-Gomez et al. used MEG to optimize tACS frequency. Also, for clinical use, tES must induce long-term after-effects (Agboada et al.). This is particularly relevant since the relatively low side-effects of tES compared to pharmacological alternatives could enforce its long-term therapeutic application (Matsumoto and Ugawa 2017). This means reporting adverse sideeffects and tES tolerability by each study to collect relevant information on how stimulation interacts with specific domains (Bikson et al. 2016). For example, Bjekic et al. compared the subjective rating of tES side-effects among healthy participants. Almost all participants (more than 95%) reported less discomfort across all tES conditions, however when compared with sham, tACS showed slightly lower levels of discomfort than tDCS and oscillatory tDCS. This research topic's collection offers a snapshot of the progress in understanding and optimizing tES in both basic and clinical neuroscience. By exploring the mechanisms of action, safety, tolerability, and clinical applications, this collection highlights the potential of tES to modulate brain activity and improve outcomes in cognitive, behavioural, and neurological domains. The insights presented here, ranging from animal models to clinical trials, provide a comprehensive framework for advancing scientific knowledge and translating it into practical strategies for therapeutic interventions. As we continue to refine tES protocols, personalize stimulation parameters, and investigate long-term after-effects, the research presented in this topic is essential for shaping the future of tES research and its clinical application.
Keywords: neuroplasticity, TACs, tDCS, tRNS, long-term effects, clinical trials
Received: 03 Jun 2025; Accepted: 05 Jun 2025.
Copyright: © 2025 Agboada, Vicario and Wischnewski. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Desmond Agboada, Universität der Bundeswehr München, Neubiberg, Germany
Carmelo Mario Vicario, Universita degli Studi di Messina, Messina, Italy
Miles Wischnewski, Rijksuniversiteit Groningen, Groningen, Netherlands
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.